Meredith Kaya | VP, IR & Corporate Communications |
Thomas McCourt | President & Interim CEO |
Gina Consylman | Principal Accounting Officer, CFO, SVP & Treasurer |
Michael Shetzline | Chief Medical Officer, SVP & Head, Drug Development |
Jacob Hughes | Wells Fargo Securities |
Hannah Adeoye | JPMorgan Chase & Co. |
David Lebowitz | Morgan Stanley |
Good day, and thank you for standing by. Welcome to the Ironwood Pharmaceuticals First Quarter 2021 Investor Update Call. [Operator Instructions]. I would now like to hand the conference over to your speaker today, Meredith Kaya, Vice President of Finance and Investor Relations. Please go ahead.